
Zhejiang Dazhan Biotechnology Co., LTD.
Zhejiang Dazhan Biotechnology Co., LTD.
Main Products:Orlistat, Moxidectin, Dextromethorphanhydrobromide,
View moreAbout Us
Contact Supplier
Hot Products
+ more
Moxidectin
Chemicals/Quaternary Ammonium Salts/Alkyl Quaternary Ammonium SaltsNegotiable
Send Inquiry
Dextromethorphanhydrobromide
Chemicals/Chemical Intermediates/Intermediate CompoundsNegotiable
Send Inquiry
Sulfachlorpyridazine sodium
Chemicals/Heterocyclic Compounds/Other Heterocyclic CompoundsNegotiable
Send Inquiry
Fluvastatin sodium salt
Health & Medical/Pharmaceuticals & Raw Materials/Chemical APIsNegotiable
Send Inquiry
Ademetionine 1,4-butanedisulfonate
Chemicals/Hydrocarbons/Other HydrocarbonsNegotiable
Send Inquiry
Ademetionine disulfate tosylate
Health & Medical/Pharmaceuticals & Raw Materials/Chemical APIsNegotiable
Send Inquiry
Glutathione
Chemicals/Pharmaceutical Raw Materials/Amino Acids & DerivativesNegotiable
Send Inquiry
Milbemycin oxime
Health & Medical/Pharmaceuticals & Raw Materials/Chemical APIsNegotiable
Send InquiryCompany Profile
+ more
Established in 2008, Zhejiang Dazhan Biotechnology Co., LTD. (formerly known as Ningbo Yijia Biochemical Co., Ltd). is a biological pharmaceutical enterprise founded by 4 peoples with oversea studying background. Through combing the advantages of these students in their majors with the practical experiences in the manufacturing fields of pharmaceuticals and chemicals, now mainly specializes in the research and development of high-end APIs and intermediates of biological pharmaceuticals both in biological and synthetic methods.
Zhejiang Dazhan Biotechnology Co., Ltd. lays great stresses on the combination of production, university and research, and establishes cooperative relations with ZhejiangUniversity of technology, ZhejiangUniversity, HuazhongAgriculturalUniversity and so on. Moreover, we have got the funding supports of governments for students with oversea studying background to start their business. Especially, our "high yield orlistat project in the mutagenesis method of bacterial strain" was approved as the National innovation fund project in 2011 successfully.